ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
0.00000000
0.00%
S&P 500
6,040.53
-0.50%
Dow Jones
44,544.66
-0.75%
US Dollar vs Yen
155.387
0.01%
Brent Oil
76.365
0.01%
Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ

  6. ArriVent BioPharma Inc (AVBP) 銘柄情報

ArriVent BioPharma Inc

ArriVent BioPharma Inc (AVBP)

NASDAQ
28.54
-0.55
(-1.89%)
終了 2月3日 6:00AM
15分遅延
28.43
-0.11
(-0.39%)
取引時間後: 9:59AM
15分遅延

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

主要統計と詳細

通貨
28.54
買値
20.22
売値
31.50
出来高
120,564
28.345 日の範囲 29.71
14.35 52 週間の範囲 36.37
時価総額
961.717M
前日終値
29.09
始値
29.06
時刻
2
@
27.12
最終取引時間
財務取引量
US$ 3,484,835
VWAP
28.9044
平均取引量 (3 か月)
153,707
発行済株式数
33,697,161
配当利回り
-
PER
-13.82
1 株当たり利益 (EPS)
-2.06
歳入
-
純利益
-69.33M

ArriVent BioPharma Inc について

ArriVent BioPharma, Inc. operates as a clinical-stage biopharmaceutical company that engages in the identification, development, and commercialization of medicines for the unmet medical needs of patients with cancers. It also engages in the development and commercialization of targeted cancer therap... ArriVent BioPharma, Inc. operates as a clinical-stage biopharmaceutical company that engages in the identification, development, and commercialization of medicines for the unmet medical needs of patients with cancers. It also engages in the development and commercialization of targeted cancer therapies for non-small-cell lung cancer (NSCLC) and other solid tumors. The company develops Furmonertinib, an epidermal growth factor receptor mutant-selective tyrosine kinase inhibitor that is in phase 3 clinical trial for the treatment of NSCLC patients; and ARR-002. It has strategic collaborations with Aarvik Therapeutics Inc. 詳細を表示

セクター
Pharmaceutical Preparations
業界
Pharmaceutical Preparations
ウェブサイト
arrivent.com
本社
Wilmington, Delaware, USA
設立
-
ArriVent BioPharma Inc is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker AVBP. The last closing price for ArriVent BioPharma was US$29.09. Over the last year, ArriVent BioPharma shares have traded in a share price range of US$ 14.35 to US$ 36.37.

ArriVent BioPharma currently has 33,697,161 shares in issue. The market capitalisation of ArriVent BioPharma is US$980.25 million. ArriVent BioPharma has a price to earnings ratio (PE ratio) of -13.82.

AVBP 最新ニュース

その他のニュース

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

2024年11月14日
Edgar (US Regulatory)

Form 8-K - Current report

2024年11月14日
Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

2024年11月13日
Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

2024年10月25日
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

2024年9月24日
Edgar (US Regulatory)

Form 8-K - Current report

2024年9月10日
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

2024年8月15日
Edgar (US Regulatory)

Form 8-K - Current report

2024年8月15日
Edgar (US Regulatory)

Form 8-K/A - Current report: [Amend]

2024年7月10日
Edgar (US Regulatory)

Form 8-K/A - Current report: [Amend]

2024年7月10日
Edgar (US Regulatory)
期間 †前日比前日比 %始値高値安値平均出来高VWAP
11.555.7428677287926.9929.6826.40516005928.54832266CS
40.732.6249550521427.8129.6823.6314119926.60652397CS
12-7.33-20.434903819335.8736.3723.6315370727.59980747CS
266.5629.845313921721.9836.3720.122321028826.51490215CS
527.5435.90476190482136.3714.3516645723.73175138CS
1564.5418.91666666672436.3714.3517336223.55895122CS
2604.5418.91666666672436.3714.3517336223.55895122CS

AVBP - Frequently Asked Questions (FAQ)

What is the current ArriVent BioPharma share price?
The current share price of ArriVent BioPharma is US$ 28.54
How many ArriVent BioPharma shares are in issue?
ArriVent BioPharma has 33,697,161 shares in issue
What is the market cap of ArriVent BioPharma?
The market capitalisation of ArriVent BioPharma is USD 980.25M
What is the 1 year trading range for ArriVent BioPharma share price?
ArriVent BioPharma has traded in the range of US$ 14.35 to US$ 36.37 during the past year
What is the PE ratio of ArriVent BioPharma?
The price to earnings ratio of ArriVent BioPharma is -13.82
What is the reporting currency for ArriVent BioPharma?
ArriVent BioPharma reports financial results in USD
What is the latest annual profit for ArriVent BioPharma?
The latest annual profit of ArriVent BioPharma is USD -69.33M
What is the registered address of ArriVent BioPharma?
The registered address for ArriVent BioPharma is 251 LITTLE FALLS DRIVE, NEW CASTLE, WILMINGTON, DELAWARE, 19808
What is the ArriVent BioPharma website address?
The website address for ArriVent BioPharma is arrivent.com
Which industry sector does ArriVent BioPharma operate in?
ArriVent BioPharma operates in the PHARMACEUTICAL PREPARATIONS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
TCTMTCTM Kids IT Education Inc
US$ 0.764
(321.87%)
729.72M
REBNReborn Coffee Inc
US$ 3.31
(63.05%)
55.54M
FCUVFocus Universal Inc
US$ 5.87
(56.62%)
1.73M
SOPASociety Pass Inc
US$ 1.54
(56.50%)
13.82M
CYCNCyclerion Therapeutics Inc
US$ 3.92
(54.33%)
82.39M
ENVBEnveric Biosciences Inc
US$ 2.0899
(-46.41%)
1.57M
NIVFNewGenIvf Group Ltd
US$ 0.1489
(-42.51%)
14.8M
GLSTGlobal Star Acquisition Inc
US$ 8.83
(-39.10%)
23.89k
PRPHProPhase Labs Inc
US$ 0.2633
(-38.02%)
872.46k
SPGCSacks Parente Golf Inc
US$ 0.5601
(-37.86%)
7.27M
TCTMTCTM Kids IT Education Inc
US$ 0.764
(321.87%)
731.1M
NVDANVIDIA Corporation
US$ 120.07
(-3.67%)
388.5M
RIMEAlgorhythm Holdings Inc
US$ 0.02565
(5.12%)
341.8M
CLEUChina Liberal Education Holdings Ltd
US$ 0.1938
(30.77%)
237.15M
BHATBlue Hat Interactive Entertainment Technology
US$ 0.0355
(-11.25%)
236.44M

AVBP Discussion

投稿を表示

最近閲覧した銘柄

NASDAQ
AVBP
ArriVent BioPharma
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2025 ADVFN PLC - 全著作権所有

広告を削除する

サインアップして広告なしのエクスペリエンスを体験してください

広告なし

今すぐ試してください

広告を残す